v3 Template
S

Slate Medicines, Inc.

Biotechnology
Founded
--
Employees
--
Total Funding
$375.0M
Funding Rounds
2
Last Funding
2026-08-17

About Slate Medicines, Inc.

Slate Medicines is a biotechnology company dedicated to developing next-generation therapeutics targeting PACAP for the treatment and prevention of migraine and other headache disorders.

Products & Services

Next-Generation Therapeutics:Therapeutics targeting PACAP for the treatment and prevention of migraine and other headache disorders. (Coming Soon)

Specialties

Therapeutics for Migraine Headache Disorder Treatments PACAP Targeting

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Private Placement
T: -
FT: Private Placement 		A: 245000000
MR: -
FA: $245M
FAN: 245000000 		D: 2026-08-17
FD: 2026-08-17 		8 investors
2 RT: Series A
T: -
FT: Series A 		A: 130000000
MR: -
FA: $130 million
FAN: 130000000 		D: 2026-02-24
FD: 2026-02-24 		4 investors
Private Placement Latest
2026-08-17
$245.0M
8 investors (Pro only)
Series A 2026-02-24
$130.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Slate Medicines, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro